Clinical Implications of the Change in Glomerular Filtration Rate with Adrenergic Blockers in Patients with Morning Hypertension:
The Japan Morning Surge-1 Study
Table 1
Baseline characteristics of patients.
Added treatment group ()
Control group ()
value
Age (years)
0.88
Male (%)
45.1
43.6
0.76
Body mass index (kg/m2)
0.82
Duration of hypertension (years)
0.74
Duration of hypertensive therapy (years)
0.34
Current smokers (%)
19.2
18.8
1.00
Habitual drinkers (%)
34.1
30.0
0.32
Diabetes or impaired glucose tolerance (%)
15.3
16.5
0.76
Hyperlipidemia (%)
32.5
40.9
0.04
Number of antihypertensive drugs
0.71
Calcium channel blockers (%)
66.6
65.6
0.82
Angiotensin-converting enzyme inhibitors (%)
13.1
15.6
0.37
Angiotensin II receptor blockers (%)
60.3
57.5
0.54
Diuretics (%)
22.0
21.9
0.93
Oral drugs for diabetes mellitus (%)
9.5
7.6
0.51
Medication for hyperlipidemia (%)
15.1
13.6
0.62
Office SBP (mmHg)
0.43
Office DBP (mmHg)
0.92
Office pulse rate (bpm)
0.11
Data are shown as the means ± SD. Urinary albumin values are expressed as the median (25% value, 75% value). BP: blood pressure; bpm: beats per minute; SBP: systolic blood pressure; DBP: diastolic blood pressure.
